Epidemiology, oncologic results and risk stratification model for metachronous peritoneal metastases after surgery for pT4 colon cancers: results from an observational retrospective multicentre long-term follow-up study
- 30 May 2023
- journal article
- research article
- Published by Springer Nature in Techniques in Coloproctology
- Vol. 27 (11) , 1025-1036
Abstract
Purpose Metachronous peritoneal metastases (MPM) following a curative surgery procedure for pT4 colon cancer is a challenging condition. Current epidemiological studies on this topic are scarce. Methods A retrospective multicentre trial was designed. All consecutive patients who underwent operations to treat pT4 cancers between 2015 and 2017 were reviewed. Demographic, clinical, operative, pathological and oncological follow-up variables were included. MPM were described as any oncological disease at the peritoneum, clearly different from a local recurrence. Univariate and multivariate Cox regression models were constructed. A risk stratification model was created on a cumulative factor basis. According to the calculated hazard ratio (HR), a scoring system was designed (HR < 3, 1 point; HR > 3, 2 points) and a scale from 0 to 6 was calculated for peritoneal disease-free rate (PDF-R). A risk stratification model was also created on the basis of these calculations. Results Fifty different hospitals were involved, which included a total of 1356 patients. Incidence of MPM was 13.6% at 50 months median follow-up. The strongest independent risk factors for MPM were positive pN stage [HR 3.72 (95% CI 2.56–5.41; p < 0.01) for stage III disease], tumour perforation [HR 1.91 (95% CI 1.26–2.87; p < 0.01)], mucinous or signet ring cell histology [HR 1.68 (95% CI 1.1–2.58; p = 0.02)], poorly differentiated tumours [HR 1.54 (95% CI 1.1–2.2; p = 0.02)] and emergency surgery [HR 1.42 (95% CI 1.01–2.01; p = 0.049)]. In the absence of additional risk factors, pT4 tumours showed 98% and 96% PDF-R in 1-year and 5-year periods based on Kaplan–Meier curves. Conclusions Cumulative MPM incidence was 13.6% at 5-year follow-up. The sole presence of a pT4 tumour resulted in high rates of PDF-R at 1-year and 5-year follow-up (98% and 96% respectively). Five additional risk factors different from pT4 status itself were identified as possible MPM indicators during follow-up.Keywords
This publication has 30 references indexed in Scilit:
- Metachronous peritoneal carcinomatosis after curative treatment of colorectal cancerEuropean Journal of Surgical Oncology, 2014
- Individualized prediction of risk of metachronous peritoneal carcinomatosis from colorectal cancerColorectal Disease, 2014
- Peritoneal Carcinomatosis in T4 Colorectal Cancer: Occurrence and Risk FactorsAnnals of Surgical Oncology, 2014
- Definition of Patients Presenting a High Risk of Developing Peritoneal Carcinomatosis After Curative Surgery for Colorectal Cancer: A Systematic ReviewAnnals of Surgical Oncology, 2012
- HIPEC in T4a colon cancer: a defendable treatment to improve oncologic outcome?Annals of Oncology, 2012
- Incidence, prevalence and risk factors for peritoneal carcinomatosis from colorectal cancerBritish Journal of Surgery, 2012
- Results of Systematic Second-look Surgery Plus HIPEC in Asymptomatic Patients Presenting a High Risk of Developing Colorectal Peritoneal CarcinomatosisAnnals of Surgery, 2011
- The Clavien-Dindo Classification of Surgical ComplicationsAnnals of Surgery, 2009
- Long-Term Prognostic Value of Conventional Peritoneal Lavage Cytology in Patients Undergoing Curative Colorectal Cancer ResectionDiseases of the Colon & Rectum, 2009
- The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studiesThe Lancet, 2007